Harry Mellor

5PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Reaction kinetics and dynamicsMetabolic medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 20, 2022
srGAP2 deactivates RhoA to control the duration of thrombin-mediated endothelial permeability.

Alba Lopez Rioja, Ashton Faulkner, Harry Mellor

|Apr 11, 2020
Raftlin is recruited by neuropilin-1 to the activated VEGFR2 complex to control proangiogenic signaling.

Asha L Bayliss, Ananthalakshmy Sundararaman, Camille Granet

Pageof 1